Dr Kay C Wiatr, MD | |
1719 Nashville St, Suite C, Russellville, KY 42276-8855 | |
(270) 726-7664 | |
(270) 726-9997 |
Full Name | Dr Kay C Wiatr |
---|---|
Gender | Female |
Speciality | Dermatology |
Location | 1719 Nashville St, Russellville, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164534038 | NPI | - | NPPES |
6415401600 | Medicaid | KY | |
1063501 | Other | KY | INDIVIDUAL PROVIDER NUMBE |
65929481 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 15401 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kay C Wiatr, MD 4667 Matlock Rd, Bowling Green, KY 42104-8712 Ph: (270) 529-6271 | Dr Kay C Wiatr, MD 1719 Nashville St, Suite C, Russellville, KY 42276-8855 Ph: (270) 726-7664 |
News Archive
The National Science Foundation BIGDATA program awarded $1,200,000 to a research team led by the University of Pittsburgh Swanson School of Engineering to study the big brain data for complex brain disorders and design new algorithms that address computational challenges in multi-site collaborative data mining.
Patients who are infected with the latent form of tuberculosis (TB) show no symptoms and are not contagious, yet they pose the biggest challenge when it comes to controlling the disease.
The Hong Kong Centre for Health Protection has confirmed a 50-year-old homeless man in Sham Shui Po has contracted Japanese encephalitis, the third case reported this year.
Staphylococcus epidermidis is an ubiquitous colonizer of healthy human skin, but it is also a notorious source of serious nosocomial infections with indwelling devices and surgical procedures such as hip replacements.
Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced that Takeda has entered into a co-promotion agreement with Janssen Pharmaceutical K.K. for VELCADEĀ® (bortezomib) for Injection, a treatment for patients with multiple myeloma.
› Verified 1 days ago